b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">29719340</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">0974-7796</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>10</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <MedlineDate>2018 Apr-Jun</MedlineDate>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Urology annals</Title>\n                <ISOAbbreviation>Urol Ann</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Embolization with Onyx<sup>\xc2\xae</sup> of an arterial pseudoaneurysm with an arteriovenous fistula complicating a percutaneous nephrolithotomy: A case report and review of literature.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>225-228</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.4103/UA.UA_29_17</ELocationID>\n            <Abstract>\n                <AbstractText>Percutaneous nephrolithotomy (PCNL) has proven very effective in the management of renal stones. However, complications are not so rare, and bleeding is one of the most worrisome; it has a reported incidence of 1%-3% and may happen during track dilatation. In addition, arterial pseudoaneurysms and/or arteriovenous fistulas (AVF) may occur. We report the case of a patient with an intrarenal pseudoaneurysm associated with an AVF, after PCNL. Superselective endovascular embolization with Onyx<sup>\xc2\xae</sup> was successfully performed, achieving exclusion of the pseudoaneurysm and AVF with preservation of the remaining vascularization of the kidney. We review the literature regarding endovascular management of kidney vascular lesions after PCNL. Selective renal embolization is a minimally invasive procedure, highly effective with a low incidence of complications. Currently, it is considered the most appropriate technique in the treatment of arterial iatrogenic complications following percutaneous renal procedures. Onyx<sup>\xc2\xae</sup> is an effective, easy to handle, and safe alternative embolic agent for these procedures.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sim\xc3\xb5es Ferreira</LastName>\n                    <ForeName>Ana Isabel</ForeName>\n                    <Initials>AI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiology, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gomes</LastName>\n                    <ForeName>Filipe Veloso</ForeName>\n                    <Initials>FV</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiology (Interventional Radiology Unit), Hepato-Biliary-Pancreatic and Transplant Center, Hospital Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bilhim</LastName>\n                    <ForeName>Tiago</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiology (Interventional Radiology Unit), Hepato-Biliary-Pancreatic and Transplant Center, Hospital Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy, Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Coimbra</LastName>\n                    <ForeName>\xc3\x89lia</ForeName>\n                    <Initials>\xc3\x89</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiology (Interventional Radiology Unit), Hepato-Biliary-Pancreatic and Transplant Center, Hospital Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D002363">Case Reports</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>India</Country>\n            <MedlineTA>Urol Ann</MedlineTA>\n            <NlmUniqueID>101510823</NlmUniqueID>\n            <ISSNLinking>0974-7796</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Arterial pseudoaneurysm</Keyword>\n            <Keyword MajorTopicYN="N">arteriovenous fistula</Keyword>\n            <Keyword MajorTopicYN="N">endovascular treatment</Keyword>\n            <Keyword MajorTopicYN="N">onyx</Keyword>\n            <Keyword MajorTopicYN="N">percutaneous nephrolithotomy</Keyword>\n        </KeywordList>\n        <CoiStatement>There are no conflicts of interest.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29719340</ArticleId>\n            <ArticleId IdType="doi">10.4103/UA.UA_29_17</ArticleId>\n            <ArticleId IdType="pii">UA-10-225</ArticleId>\n            <ArticleId IdType="pmc">PMC5907337</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cardiovasc Intervent Radiol. 2009 Jan;32(1):163-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18389183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tech Vasc Interv Radiol. 2007 Dec;10 (4):299-307</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18572145</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rofo. 2009 Oct;181(10 ):996-1001</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19780006</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Urol. 2007 Feb;177(2):576-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17222636</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nephrourol Mon. 2014 Sep 05;6(5):e19037</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25695029</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vasa. 2014 Nov;43(6):459-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25339164</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Urology. 2005 Jul;66(1):38-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15992882</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Radiol. 2000;10 (8):1358</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10939509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'